For the Quarter Ending December 2022
In the fourth quarter of 2022, Losartan Potassium prices decreased somewhat in North America compared to the previous quarter. The CFR New York prices dropped from USD 81200/MT to USD 81220/MT from October to December by 0.93%. As per the market players, the US domestic market ended the year on a downward note because the demand in the end-user pharmaceutical and healthcare sector weakened. Even as importers expressed that disruptions related to Covid-19 in China had potentially brought greater hardship, costs declined throughout US supply chains, alleviating inflationary pressures. However, the US supply chains became more flexible entering December as a result of lower shipping demand brought on by slower consumer spending and a reduction in manufacturing activity.
During the fourth quarter of 2022, the price of Losartan Potassium across the Asia Pacific region displayed a downward price trajectory. Between October and December, FOB Shanghai prices in China decreased from USD 65000/MT to USD 64800/ MT. Due to the closure of production facilities for the Golden Week, orders for Losartan Potassium for China's API market slightly decreased during the first week of October. Domestic merchants encountered a lot of contradicting signals following a one-week holiday and the market's reopening, which made it difficult for the players to keep up with the slow development seen in the downstream industries. Offtakes in the pharmaceutical sectors remained moderate in terms of demand throughout the quarter. Despite China's steps to broaden relaxations in Covid-19 curbs in response to a massive protest outburst in late November, the market witnessed pessimistic sentiments. The manufacturers had slowed down their production and were mainly focused on selling off their stocks even at cheap rates due to the ongoing yearlong destocking season.
In Europe, the German market for Losartan Potassium followed the same pattern as North America and Asia. The CFR Hamburg prices were resolved at USD 74600/ MT in October and USD 74500/ MT in December, indicating a downward trend. Demand from the downstream pharmaceutical sector was higher in the first half of the quarter than in the second half due to the unexpected rise in coronavirus infections, which caused a decrease in orders. In terms of supply, market players had sufficient stocks with them to meet any immediate order. However, Germany's annual inflation rate moderated in December, as observed from German CPI, which fell to 8.6% in December from 10% in November, measured according to EU-national standards. Also, Germany's trade flows had resumed at a more significant level, but the market's fundamentals remained weak, resulting in lower prices.
For the Quarter Ending September 2022
The Losartan Potassium market showcased an overall increasing pricing trend in the North American region during the third quarter of 2022. In the United States market, the prices inclined considerably with the onset of Q3 owing to limited inventories with the local vendor amidst high offtakes from downstream producers. However, the demand in the mid of Q3 went on the lower side, with prices declining to USD 80000/MT. Soon after, some production activities in exporting countries, including China and India, decreased owing to worsened weather conditions, affecting the imports to the US. Therefore, the Losartan Potassium market dynamics got surged over the end of Q3 in the USA, with CFR New York prices settling at USD 82000/MT.
During the third quarter of 2022, the price trend of Losartan Potassium inclined significantly by 3.1%, with a buoyant market sentiment in the Asia-Pacific region. The price surged to USD 64500/MT was backed by a shortage of inventories with local vendors. Furthermore, the continuous lockdown restriction and port congestion led to shipments piling up, which supported the market's pricing tendency. Moving towards the second half of Q3, the prices increased, further supported by higher downstream demand and inquiries from the domestic market. Some production activities decreased owing to worsened weather conditions, keeping the suppliers from raising their rates to gain profits. Overall, prices escalated by the end of the third quarter with the settlement of USD 65800/MT FOB Shanghai in China.
The market fundamentals for Losartan Potassium in Europe were comparable to those in North America in the Q3 of 2022. In July, the German Losartan Potassium commenced the quarter positively, with prices settling at USD 74650/MT. However, prices started declining from mid-H1 and inclined again in the last weeks of the quarter. Therefore, constant fluctuation in price trends was owing to various factors, such as the unstable supply of inventories in the domestic market and fluttering demand from the end-user pharmaceutical sector. In addition, turbulences in logistic activities, piled-up cargo at the port, and variations in seasonal conditions in the major exporting country, China, affected the Losartan Potassium market. Towards the end of Q3 of 2022, Losartan Potassium prices were evaluated at USD 75540/MT for CFR Hamburg.
During the second quarter of 2022, prices of Losartan Potassium have witnessed a downward trajectory in the North American region on the back of the adequate supply of the API with the end-user manufacturers. On the other side, the requirement from the end-user pharmaceutical industries has remained bearish. As a result, the manufacturers were obliged to reduce the production rate, which negatively impacted the prices of Losartan Potassium. Also, regular supply and sufficient stocks with the suppliers have different facets for the lower costs of Losartan Potassium across the regional market. Thus, Losartan Potassium prices were assessed at USD 80750/MT for CFR New York Towards the end of Q2 of 2022.
During the second quarter of 2022, Losartan Potassium Market has continued to rise in the APAC region owing to the crippling availability of a product in the APAC region. In addition, the high cost of the starting material like Phenyl Tetrazole has further weighed on the high prices of Losartan Potassium. On the other hand, higher downstream demand from various end-user enterprises caused the Losartan Potassium API to increase. Moreover, the trade-related disruption amidst the temporary shutdown of manufacturing units in China due to the lockdown in several cities impacted the market price of Losartan Potassium across the region. Besides, mounting demand resulted in a container shortage with the traders, which led to the high maritime cost and supported the price increment of API in the regional market. Thus, Losartan Potassium prices settled at INR 5320000/MT for Ex-Vapi in June 2022.
Prices of Losartan Potassium have shown a positive market sentiment in the European region during the second quarter of 2022. The demand for Losartan Potassium API drugs remained bullish, leading to high market prices of the product in the regional market. On the other hand, the inflation rate in the country remained high during the second quarter, which consequently surged the API prices across the regional market. On the supply front, the transportation of the API from exporting country India remained frenzy as the freight charges remained upbeat, followed by the tight German ports. Demand from pharmaceutical sectors that is Losartan Potassium producing companies remained active, leading to the solid demand for the product in the regional market. Towards the end of Q2 of 2022, Losartan Potassium prices were evaluated at USD 73750/MT for CFR Hamburg.